Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

ClinicalTrials.gov ID: NCT00254202

Public ClinicalTrials.gov record NCT00254202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Iloperidone in Schizophrenic Patients in Acute Exacerbation Followed by a Long-term Treatment Phase.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and efficacy of iloperidone compared to placebo and an active comparator in the treatment of patients with schizophrenia in acute exacerbation.

Study identification

NCT ID
NCT00254202
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
593 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2005 (Actual)
Primary completion
Sep 26, 2006 (Actual)
Completion
Mar 21, 2007 (Actual)
Last update posted
Oct 6, 2026

2005 – 2007

United States locations

U.S. sites
33
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Vanda Investigational Site Little Rock Arkansas 72211 —
Vanda Investigational Site Anaheim California 92805 —
Vanda Investigational Site Cerritos California 90703 —
Vanda Investigational Site Garden Grove California 92845 —
Vanda Investigational Site Glendale California 91206 —
Vanda Investigational Site Los Angeles California 90048 —
Vanda Investigational Site National City California 91950 —
Vanda Investigational Site Oceanside California 92056 —
Vanda Investigational Site Paramount California 90723 —
Vanda Investigational Site Pico Rivera California 90660 —
Vanda Investigational Site San Diego California 92123 —
Vanda Investigational Site San Diego California 92126 —
Vanda Investigational Site San Diego California 92161 —
Vanda Investigational Site Santa Ana California 92705 —
Vanda Investigational Site Upland California 91786 —
Vanda Investigational Site Bradenton Florida 34208 —
Vanda Investigational Site Fort Lauderdale Florida 33308 —
Vanda Investigational Site Maitland Florida 32751 —
Vanda Investigational Site Atlanta Georgia 30308 —
Vanda Investigational Site Augusta Georgia 30912 —
Vanda Investigational Site Hoffman Estates Illinois 60194 —
Vanda Investigational Site Lake Charles Louisiana 70601 —
Vanda Investigational Site Rockville Maryland 20850 —
Vanda Investigational Site Saint Charles Missouri 63301 —
Vanda Investigational Site St Louis Missouri 63118 —
Vanda Investigational Site Clementon New Jersey 08021 —
Vanda Investigational Site Brooklyn New York 11203 —
Vanda Investigational Site Cincinnati Ohio 45267 —
Vanda Investigational Site Philadelphia Pennsylvania 19131 —
Vanda Investigational Site Austin Texas 78756 —
Vanda Investigational Site Houston Texas 77057 —
Vanda Investigational Site Irving Texas 75062 —
Vanda Investigational Site Richmond Virginia 23229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00254202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00254202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →